Cincinnati Clinical Research Site (Site ID: 2401)

Cincinnati, Ohio 45267-0405

0 studies enrolling now · 1 studies all time

What they study most

HIV Infections, Non-Alcoholic Fatty Liver Disease

Studies at this site

• Study of Semaglutide for Non-Alcoholic Fatty Liver Disease (NAFLD), a Metabolic Syndrome With Insulin Resistance, Increased Hepatic Lipids, and Increased Cardiovascular Disease Risk (The SLIM LIVER Study) — Completed